Gordon Findlay, a Novo Nordisk executive, collapsed suddenly during a press conference in the Oval Office. The event was held to announce a new deal on weight-loss medications with the Trump administration.
Findlay was standing behind President Donald Trump when his knees gave out. Officials and pharmaceutical representatives quickly intervened to prevent him from falling to the floor.
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.” – White House Press Secretary Karoline Leavitt
Dr. Mehmet Oz, Administrator for Centers for Medicare & Medicaid Services, aided Findlay by helping him to the ground safely to avoid head injury. Following the incident, reporters were escorted out of the Oval Office while cabinet members attended to Findlay and elevated his legs.
The press conference was set to continue shortly after the medical team ensured Findlay’s condition was stable.
Author's summary: A Novo Nordisk executive unexpectedly fainted during a White House event on weight-loss medication, receiving immediate medical assistance, with the press conference resuming soon after.